Lv3
230 积分 2023-07-27 加入
A tetraspecific engager armed with a non-alpha IL-2 variant harnesses natural killer cells against B cell non-Hodgkin lymphoma
16天前
已完结
Immune-mediated liver injury
20天前
已完结
Next-generation anti-PD-L1/IL-15 immunocytokine elicits superior antitumor immunity in cold tumors with minimal toxicity
22天前
已完结
An engineered concealed IL-15-R elicits tumor-specific CD8+T cell responses through PD-1-cis delivery
23天前
已完结
Tumor-conditional IL-15 pro-cytokine reactivates anti-tumor immunity with limited toxicity
23天前
已完结
Recent advances in pluripotent stem cell-derived cardiac organoids and heart-on-chip applications for studying anti-cancer drug-induced cardiotoxicity
1个月前
已完结
In vivo dendritic cell reprogramming for cancer immunotherapy
2个月前
已完结
CAF-induced physical constraints controlling T cell state and localization in solid tumours
2个月前
已完结
Clinical Grade Manufacture of CYAD-101, a NKG2D-based, First in Class, Non–Gene-edited Allogeneic CAR T-Cell Therapy
2个月前
已完结
Long-term engrafting multilineage hematopoietic cells differentiated from human induced pluripotent stem cells
3个月前
已完结
皖公网安备34019202002308
